NCT00406237View on ClinicalTrials.gov

Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Liver Cirrhosis, Biliary
Interventions
DRUG

tigecycline

Single intravenous dose of tigecycline 50 mg, as a 30-minute infusion

Trial Locations (3)

27710

Pfizer Investigational Site, Durham

55114

Pfizer Investigational Site, Saint Paul

00909

Pfizer Investigational Site, Santurce

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00406237 - Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis | Biotech Hunter | Biotech Hunter